Arcutis Biotherapeutics, Inc. ARQT Total debt

Total debt at other companies

PfizerPFE

$64.43B+4.9%

AmgenAMGN

$57.3B+2.0%

IncyteINCY

$38.27M-9.8%

PVL

Palvella TherapeuticsPVLA

$584K—

Celldex TherapeuticsCLDX

$4.9M+61.8%

Kymera TherapeuticsKYMR

$80.14M-8.5%

FAQ

What is Arcutis Biotherapeutics, Inc.'s total debt?

Arcutis Biotherapeutics, Inc. (ARQT) reported total debt of $114.14M in Q2 2026.

How has Arcutis Biotherapeutics, Inc.'s total debt changed year-over-year?

Arcutis Biotherapeutics, Inc.'s total debt increased by 3.6% year-over-year, from $110.16M to $114.14M.

What is the long-term trend for Arcutis Biotherapeutics, Inc.'s total debt?

Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s total debt has grown at a 87.3% compound annual growth rate (CAGR), from $4.96M to $114.52M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.